Universal Flu vaccine’s positive trial results confirmed

Final results of BiondVax’s Phase 2b trials of its Universal Flu vaccine confirmed preliminary results reported here previously. (5 Feb) Both endpoints were met. Immune response to the vaccine was statistically significant. BiondVax can now proceed to Phase 3 final trials.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *